Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Antibody Response of Tdap in Plasma Donors
NCT04142983Phase 3Completed
- Sponsor
- GCAM
- Start
- Feb 2020
- Primary completion
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of acellular pertussis vaccine in Tetanus, sponsored by GCAM. Started Feb 2020; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT04142983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04142983.